n-803
immunitybio
['quilt,3.032', 'bladder']
karim chamie : 96% of people with non-muscle-invasive #bladdercancer carcinoma in situ unresponsive to bcg who got in-bladder immunotherapy (n-803) + bcg had bladder-cancer-specific progression-free survival at 2 years #asco22 quilt 3.032 
she/her. CEO of @BladderCancerUK. President of @WorldBladderCan. Board member at @EauPatient. ??????????????????????????